G3 Therapeutics

G3 Therapeutics is a global leader in applying unbiased bio-big data to transform the drug discovery and drug development process. G3 Therapeutics has built an inspiring platform that leverages deep phenotyping, deep molecular analysis, and deep learning to discover, validate, and develop new drug targets. The foundational bio-big data platform of G3 Therapeutics is based on the GLOBAL clinical study (NCT01738828), recruiting over 7,500 individuals from around the world. G3 Therapeutics' deep molecular analysis approach includes whole-genome sequencing, as well as measurements of all other relevant "omics," including DNA methylation, RNA sequencing, proteomics, metabolomics, and lipidomics.